US Patent 11633393 Tubulin binding compounds and therapeutic use thereof

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116333930

Patent Inventor Names

Santosh Ambadas Khedkar0

Lan Huang0

Michel O. Steinmetz0

Date of Patent

April 25, 2023

Patent Application Number

164762420

Date Filed

January 5, 2018

Patent Citations

‌

US Patent 10238650 Method of treating cancer associated with a RAS mutation

‌

US Patent 10357491 Method of treating a brain tumor

‌

US Patent 10569169 Data processing method and apparatus for network system

‌

US Patent 10550104 Plinabulin compositions

‌

US Patent 10596169 Cancer treatment with combination of plinabulin and taxane

‌

US Patent 10076518 Method of treating a brain tumor

‌

US Patent 10155748 Plinabulin compositions

Patent Primary Examiner

CPC Code

Disclosed herein are compounds that can bind to tubulin and activate GEF-H1. Methods of using these compounds for treating cancer are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11633393 Tubulin binding compounds and therapeutic use thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11633393 Tubulin binding compounds and therapeutic use thereof